We have updated our Privacy Statement. You can view our latest Privacy Statement here X

  • Conventional Injection Therapy 
    2 to 3 injections per day of mixed long- and short-acting insulin.
  • Multiple Daily Injections​​​​​​​
    Injecting 3 or more times per day with rapid-acting insulin and 1 to 2 times per day with long-acting insulin.
  • Insulin Pump (Continuous Subcutaneous Insulin Infusion – CSII) ​​​​​​​
    CSII replaces the need for frequent injections by delivering rapid-acting insulin 24 hours a day. A programmed insulin rate mimics the basal insulin production by the pancreas and can be better adjusted to the body's needs. Rapid-acting of insulin acts very quickly to help minimise variations in blood glucose levels in response to carbohydrate intake or, if needed, to lower high blood glucose values.

 

REDUCE HBA1C, REDUCE COMPLICATIONS

HbA1c: an important measure of how effectively diabetes can be managed using a measure of the amount of glucose that has attached itself to each red blood cell over the preceding 2 to 3 months to assess the level of diabetes control.

The DCCT (Diabetes Control and Complications Trial) study confirmed that lowering HbA1c by just 1% can decrease the risk of developing microvascular complications by up to 40%*. HbA1c should be monitored every 3 months with the goal of keeping it below 7% (53 mmol/L) or at the target set by your diabetes healthcare team*.

Normal glucose values vary between 4.0 and 7.8 mmol/L, and you may want to consider trying to achieve these targets in daily life with self-monitoring of blood glucose (SMBG) levels using a personal glucose meter*.

It can be a challenge to reach and maintain the HbA1c goal whilst minimising the risk of hypoglycaemia. Insulin pump therapy enables adjustment in insulin requirements to meet the body's hourly needs.